LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY

Ketter Terence A.; Sarma Kaushik; Silva Robert; Kroger Hans; Cucchiaro Josephine; Loebel Antony

首页> 外文期刊>Depression and anxiety >LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY

【24h】

LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY

机译：卢拉西酮在双歧性疾病患者的长期治疗中：24周开放式扩展研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe aim of this study was to evaluate the safety and tolerability of 6 months of open-label, uncontrolled extension treatment with lurasidone in patients with a diagnosis of bipolar depression who completed 6 weeks of acute treatment.

机译：背景本研究的目的是评估在完成了6周急性治疗的双相抑郁症诊断中使用Lurasidone进行6个月开放标签，不受控制的扩展治疗的安全性和耐受性。

著录项

来源
《Depression and anxiety 》 |2016年第5期| 共11页
作者
Ketter Terence A.; Sarma Kaushik; Silva Robert; Kroger Hans; Cucchiaro Josephine; Loebel Antony;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类 R749.72;
关键词
bipolar disorder; bipolar depression; lurasidone; antipsychotic agents; lithium; valproate; depressive disorder; major depression;

机译：躁郁症;躁郁症;拉西酮;抗精神病药;锂;丙戊酸盐;抑郁症;重度抑郁;

相似文献

外文文献
中文文献
专利

1. LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY [J] . Ketter Terence A., Sarma Kaushik, Silva Robert, Depression and anxiety . 2016 ,第5期

机译：卢拉西酮在双歧性疾病患者的长期治疗中：24周开放式扩展研究
2. Effectiveness of long-term treatment with lurasidone in children and adolescents with bipolar depression: week 28 results of a 2-year open-label extension study [J] . Chang K., DelBello M., Goldman R., Bipolar disorders. . 2018 ,第Suppla1期

机译：长期治疗与双极抑郁症儿童和青少年长期治疗的有效性：第28周28个开放标签扩展研究结果
3. Safety of long-term treatment with lurasidone in children and adolescents with bipolar depression: week 28 results of a 2-year open-label extension study [J] . Chang K., DelBello M., Goldman R., Bipolar disorders. . 2018 ,第Suppla1期

机译：含有双极抑郁症儿童和青少年的长期治疗的安全性：第28周的28个开放标签扩展研究结果
4. Supporting situational awareness through a patient overview screen for bipolar disorder treatment [C] . Frost Mads, Gabrielli Silvia 2013 7th International Conference on Pervasive Computing Technologies for Healthcare and Workshops . 2013

机译：通过患者概述屏幕支持双相情感障碍治疗的态势感知
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. LURASIDONE IN THE LONG‐TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24‐WEEK OPEN‐LABEL EXTENSION STUDY [O] . Terence A. Ketter, Kaushik Sarma, Robert Silva, -1

机译：卢拉西酮在双歧性疾病患者的长期治疗中：一项为期24周的开放标签扩展研究
7. A 24-Week, Open-Label Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of 13.3 mg/24 h Rivastigmine Patch in Patients With Severe Alzheimer Disease [O] . Farlow Martin R., Grossberg George T., Sadowsky Carl H., 2015

机译：一项为期24周的开放标签扩展研究，用于研究重度阿尔茨海默氏病患者中13.3 mg / 24 h Rivastigmine贴剂的长期安全性，耐受性和功效

LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY

摘要

著录项

相似文献

相关主题

期刊订阅